Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

548
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
548
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

489
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
489

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and optimization of a novel, cranially-mounted deep brain stimulation device for children with epilepsy - the CADET Pilot study.

Brain stimulation·2026
Same author

Application of Electric-Field-Optimized Augmented Reality-Guided Neuronavigation in Transcranial Magnetic Stimulation.

Journal of clinical medicine·2026
Same author

Repetitive transcranial magnetic stimulation as adjunctive therapy in adult patients with drug-resistant epilepsy-A systematic review and meta-analysis.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

Electrical Cortical Stimulation for Language Mapping in Epilepsy Surgery-A Systematic Review.

Brain sciences·2025
Same author

Trigeminal Microvascular Decompression for Medically Refractory Short-Lasting Unilateral Neuralgiform Headache Attacks: A Single-Center Retrospective Analysis.

World neurosurgery·2025
Same author

Seizure forecasting by tracking cortical response to electrical stimulation.

Epilepsia·2025

Related Experiment Video

Updated: Oct 28, 2025

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

25.9K

Neuromodulation in Super-refractory Status Epilepticus.

Ioannis Stavropoulos1,2, Ho Lim Pak3, Antonio Valentin1,2

  • 1Department of Clinical Neurophysiology, King's College Hospital, London, United Kingdom.

Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society
|July 14, 2021
PubMed
Summary

Super-refractory status epilepticus (srSE) is a severe condition often resistant to standard treatments. Neuromodulation techniques show promise in aborting srSE in over 80% of patients, though further research is needed.

More Related Videos

Non-Invasive Electrical Brain Stimulation Montages for Modulation of Human Motor Function
07:47

Non-Invasive Electrical Brain Stimulation Montages for Modulation of Human Motor Function

Published on: February 4, 2016

13.3K
Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
10:24

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Published on: May 15, 2018

14.9K

Related Experiment Videos

Last Updated: Oct 28, 2025

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

25.9K
Non-Invasive Electrical Brain Stimulation Montages for Modulation of Human Motor Function
07:47

Non-Invasive Electrical Brain Stimulation Montages for Modulation of Human Motor Function

Published on: February 4, 2016

13.3K
Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
10:24

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Published on: May 15, 2018

14.9K

Area of Science:

  • Neurology
  • Neurosurgery
  • Critical Care Medicine

Background:

  • Status epilepticus (SE) is a medical emergency requiring prompt treatment to prevent brain damage.
  • Refractory SE (RSE) occurs when standard treatments fail, affecting approximately 20% of SE cases.
  • Super-refractory SE (srSE) is defined as RSE lasting over 24 hours despite anesthetic treatment, posing a severe risk of brain injury.

Purpose of the Study:

  • To review clinical neuromodulation techniques for managing super-refractory status epilepticus (srSE).
  • To evaluate the efficacy of neuromodulation when conventional treatments for srSE have failed.

Main Methods:

  • Review of clinical neuromodulation techniques including electroconvulsive therapy, vagus nerve stimulation, transcranial magnetic stimulation, and deep brain stimulation.
  • Analysis of data from retrospective case series and case reports on neuromodulation for srSE.

Main Results:

  • Neuromodulation therapies demonstrated the ability to abort srSE in over 80% of patients.
  • Current evidence is primarily derived from small, retrospective studies with potential publication bias.

Conclusions:

  • Neuromodulation offers a potential therapeutic option for srSE when other treatments fail.
  • There is a critical need for randomized, prospective trials to validate these findings.
  • Further investigation is required to determine if earlier neuromodulation intervention can prevent long-term complications of srSE.